A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation.

Seoung Hoon KimEung Chang LeeJae Ryong ShimSang Jae Park

Published in: Liver international : official journal of the International Association for the Study of the Liver (2017)

A simplified protocol using rituximab and IVIG for ABO-I LDLT was safe and effective in achieving sufficient desensitization and comparable outcomes in patients with the titre no higher than 1:64.

Keyphrases

diffuse large b cell lymphoma
randomized controlled trial
chronic lymphocytic leukemia
hodgkin lymphoma
type diabetes
adipose tissue
metabolic syndrome
insulin resistance